Projects per year
Fingerprint
Dive into the research topics where Emma Verheye is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 1 Active
-
ANI323: Personalized tumor-derived dendritic cell therapy to overcome residual disease in multiple myeloma
1/11/22 → 31/10/23
Project: Fundamental
-
Targeting the β2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism
Satilmis, H., Verheye, E., Vlummens, P., Oudaert, I., Vandewalle, N., Fan, R., Knight, J., De Beule, N., Ates, G., Massie, A., Moreaux, J., Maes, A., De Bruyne, E., Vanderkerken, K., Menu, E., Sloan, E. & De Veirman, K., Jan 2023, In: Journal of pathology. 259, 1, p. 69–80 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma
Fan, R., Satilmis, H., Vandewalle, N., Verheye, E., Vlummens, P., Maes, A., Muylaert, C., De Bruyne, E., Menu, E., Evans, H., Chantry, A., De Beule, N., Hose, D., Töngren, M., Eriksson, H., Vanderkerken, K., Maes, K., Breckpot, K. & De Veirman, K., 17 Jan 2023, In: Journal for ImmunoTherapy Of Cancer. 11, 1, A8.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions
Verheye, E., Melgar, J. B., Deschoemaeker, S., Raes, G., Maes, A., De Bruyne, E., Menu, E., Vanderkerken, K., Laoui, D. & De Veirman, K., 14 Jan 2022, In: International Journal of Molecular Sciences. 23, 2, 904.Research output: Contribution to journal › Scientific review › peer-review
Open Access14 Citations (Scopus) -
Dendritische cellen als immunotherapie voor multipel myeloom
Verheye, E., De Beule, N., Laoui, D. & De Veirman, K., 2022, In: OncoHemato. 16, 3, p. 35-38 4 p.Research output: Contribution to journal › Article › peer-review
-
The multifaceted anti-cancer effects of the immunomodulator Tasquinimod in Multiple Myeloma
Fan, R., Verheye, E., Satilmis, H., Vandewalle, N., De Bruyne, E., Menu, E., De Beule, N., Hose, D., Vanderkerken, K., Breckpot, K., Maes, K. & De Veirman, K., 4 Feb 2022.Research output: Unpublished contribution to conference › Poster
Activities
- 2 Talk or presentation at a conference
-
AXL targeting using Bemcentinib increases chemosensitivity in Acute Myeloid Leukemia
Niels Vandewalle (Speaker), Laura Meysman (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Rong Fan (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
-
Mapping the immune heterogeneity within the myeloma microenvironment using single-cell transcriptomics
Emma Verheye (Speaker), Rong Fan (Contributor), Hatice Satilmis (Contributor), Niels Vandewalle (Contributor), Pauline Bardet (Contributor), Emile Clappaert (Contributor), Daliya Kancheva (Contributor), Elke De Bruyne (Contributor), Karin Vanderkerken (Contributor), Kim De Veirman (Contributor) & Damya Laoui (Contributor)
3 Feb 2023Activity: Talk or presentation › Talk or presentation at a conference
Thesis
-
Daily management of an animal facility in preparation of AAALAC acreditation
Author: Verheye, E., 2020Supervisor: Hellemans, K. (Promotor)
Student thesis: Master's Thesis
-
Stress hormone signalling contributes to myelomagenesis by effects on immune cells and tumor cells
Author: De Veirman, K. & Verheye, E. M., 2021Student thesis: Master's Thesis